We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Next-Generation Sequencing: Tracking the Spread and Evolution of SARS-CoV-2
Industry Insight

This article explores how next-generation sequencing (NGS) is being used to help track the spread and evolution of SARS-CoV-2, including pinpoint the different lineages of the virus and identifying patterns of its movement both globally as well as locally.

Read More

Can You Achieve Rapid MS Analysis with No Sample Prep?
Industry Insight

News of how innovations can assist scientists and their workflows is not uncommon, but claims of “industry revolutions”, however, tend to be a little less frequent. The Echo® MS System from SCIEX is touted as being one such revolution, we spoke to Neil Walsh to learn more.

Read More

A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic
Industry Insight

The ACE2 receptor has garnered significant attention for the wrong reasons over recent months. Could it point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist Professor Josef Penninger explains why he thinks so, and discusses the latest clinical data obtained from testing the soluble ACE2 receptor, APN01.

Read More

LAMP-Based Testing for COVID-19
Industry Insight

Technology Networks recently spoke to Dr Gary Keating, Chief Technical Officer at Hibergene Diagnostics, to learn more about LAMP technology and the advantages it could offer for COVID-19 testing. Gary also discussed some of the challenges faced when developing diagnostics and how the COVID-19 pandemic has impacted diagnostic design and manufacturing.

Read More

From Vaccine Printers to DNA Data Storage, What's in Store for the Future of Synthetic Biology?
Industry Insight

Scientists are harnessing the power of synthetic biology – a field of science that involves redesigning biological components to generate novel synthetic entities – to solve scientific problems and drive innovation in medicine. Technology Networks recently spoke with Codex DNA’s CEO Todd R. Nelson to learn about the impact synthetic biology techniques are having on pharmaceutical development and the "big trends" in synthetic biology we are already seeing and are expected to see in the next few years.

Read More

Progress in Companion Diagnostic Development for Low-Grade Glioma
Industry Insight

To learn about the benefits of accelerating turnaround times for genomic testing and the importance of partnering with pharma companies to develop companion diagnostics, Technology Networks spoke with Luca Quagliata, PhD, BCMAS, Global Director of Medical Affairs for Thermo Fisher Scientific.

Read More

New RNA Extraction Strategies Help Mitigate Shortages in SARS-CoV-2 PCR Components
Industry Insight

As the world continues to battle through the pandemic, developing innovative strategies to expand the availability of extraction, and any other testing components that are facing supply issues, will be an ongoing requirement.

Read More

Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2
Industry Insight

A team of multidisciplinary scientists – including bioengineers, materials-scientists and immunologists – at the Wyss Institute has created a novel infection vaccine platform know as OmniVax. Technology Networks spoke with Lead Senior Staff Scientist Ed Doherty from the Wyss Institute for Biologically Inspired Engineering at Harvard University, to learn more.

Read More

Targeting “Undruggable” Proteins by Selectively Controlling mRNA Translation
Industry Insight

Up to 80% of proteins do not possess binding sites suitable for direct binding of small molecule drugs, making them “undruggable”. To overcome this problem, Anima Biotech has developed a platform to identify drugs with the ability to interfere with the production of these “undruggable” proteins, by selectively inhibiting the translation of mRNA.

Read More

CRISPR: Tips and Tricks for Efficient Delivery Into Primary Cells and Cell Lines
Industry Insight

This article provides tips and tricks for efficient delivery of CRISPR genome editing technology into primary cells and cell lines.

Read More

 
Advertisement